Filter Results:
(1,011)
Show Results For
- All HBS Web
(1,011)
- People (3)
- News (261)
- Research (631)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
Show Results For
- All HBS Web
(1,011)
- People (3)
- News (261)
- Research (631)
- Events (1)
- Multimedia (6)
- Faculty Publications (295)
- 25 Apr 2014
- News
Bringing a new funding model to the life sciences industry
health care. "It's essentially a form of equity crowdfunding," Farquharson explains. "Since our focus is on breakthroughs in health care, success translates to dramatic improvements in clinical outcomes."... View Details
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- November 2003 (Revised September 2008)
- Case
Circle Gastroenterology Products (A)
By: Regina E. Herzlinger and James Weber
A new, minimally invasive medical device has achieved only one-third of its budget. Was the problem one of marketing strategy, sales, reimbursement, and/or clinical trials? View Details
Keywords: Health Testing and Trials; Marketing Strategy; Product Marketing; Sales; Medical Devices and Supplies Industry
Herzlinger, Regina E., and James Weber. "Circle Gastroenterology Products (A)." Harvard Business School Case 304-052, November 2003. (Revised September 2008.)
- February 2020
- Supplement
Theranos: Who Has Blood on Their Hands? (B)
By: Nien-he Hsieh, Christina R. Wing and John Masko
This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019. View Details
Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Lawsuits and Litigation; Business Exit or Shutdown; Medical Devices and Supplies Industry; California; United States
Hsieh, Nien-he, Christina R. Wing, and John Masko. "Theranos: Who Has Blood on Their Hands? (B)." Harvard Business School Supplement 320-091, February 2020.
- 09 Mar 2015
- Research & Ideas
Why Entrepreneurs Should Go Work for Government
"private-public entrepreneurs" who establish private businesses that sell to government agencies or sometimes to citizens directly. In Philadelphia, for example, Textizen enables citizens to communicate with city health View Details
Keywords: by Michael Blanding
- October 2020
- Teaching Plan
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
and commercialize medical diagnostic tools that will, ultimately, improve health outcomes. Lee’s DZD was one of the inaugural startups in 2016 at the Life Lab, a state-of-the-art wet lab View Details
Keywords: Susan Young
- 2009
- Case
Innovamedica: Innovation in an Emerging Market
By: Roberto Charvel, Fernando Fabre and T. Putimahtama
Innovamedica was a medical start up with several state of the art devices such as a silicon substitute heart and other inventions. However, the founding scientist was struggling in attracting talent and fundraising and that had an impact on growth. View Details
Keywords: Biotech; Entrepreneurial Finance; Entrepreneurship; Start-up; Emergent Countries; Business Startups; Talent and Talent Management; Design; Corporate Entrepreneurship; Private Equity; Health Testing and Trials; Innovation and Invention; Managerial Roles; Biotechnology Industry; Latin America; North and Central America
Charvel, Roberto, Fernando Fabre, and T. Putimahtama. "Innovamedica: Innovation in an Emerging Market." Instituto Panamericano de Alta Dirección de Empresa (IPADE) Case (P)DGe-440, 2009.
- 15 Jan 2021
- News
To Overcome Vaccine Hesitancy, We Need a Better Patient Experience
- Web
HBS - The year in Review
MBA students—reflecting a generous deferral and leave policy—enrolled. Doctoral classes were held entirely online. Health & Well-Being on Campus Throughout the year, students, faculty, View Details
- 01 Feb 2002
- News
It's academic. (Not!)
business administration (DBA) in accounting and control, marketing, policy and management, or technology and operations management. Another option is a joint program with... View Details
- 01 Jun 2022
- News
The Exchange: Same Great Price, Now with Fewer Chips
health preferences and tastes. Some customers may prefer smaller portions. Meanwhile, the prices for certain organic foods and things like wild-caught fish seem to be going up... View Details
- 13 Feb 2013
- Research & Ideas
5 Weight Loss Tips From Behavioral Economists
Weight Loss: A Randomized, Controlled Trial," published in the June 2011 edition of Journal of General Internal Medicine. TIP #3- Fill your backpack with rocks. A research team from Harvard and the University of Central Florida View Details
Keywords: by Carmen Nobel
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- 1996
- Chapter
The Determinants of Research Productivity in Ethical Drug Discovery
By: Rebecca M. Henderson and Ian Cockburn
- Web
Harvard Business School
IlliniCare Health in August 2017. Rashid is a pioneer in the Medicaid managed care landscape, helping to ensure there is access to quality and affordable health care to the... View Details
- Web
2024 Reunion Presentations - Alumni
available + More Info – Less Info After spreading rapidly in the late 20th century, democracy has been on the defensive around the world—and arguably receding—in the 21st century. This represents a profound threat to freedom and... View Details
- 28 Nov 2011
- Research & Ideas
Rethinking the Fairness of Organ Transplants
distribution of recipients across different groups by age, race, diagnosis, and blood type. "This gives policymakers the ability to focus on what's important and relevant," he adds. "Right... View Details
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
aspects of the drug trial and approval process, including allowing time for potential issues to materialize. When you see an FDA emergency approval for a COVID-19 vaccine, don't interpret this as a normal... View Details